Skip to content
10-Q

Quarterly Report

VERVE THERAPEUTICS, INC.

0000950170-24-093327

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 1, 2024 84.62M sh
Shares Diluted Q2 2024 · Jun 30, 2024 84.23M sh
Shares Diluted Q2 2024 · Jun 30, 2024 83.68M sh
Shares Diluted Q2 2024 · Jun 30, 2023 61.95M sh
Shares Diluted Q2 2024 · Jun 30, 2023 61.87M sh
Capex Q2 2024 · Jun 30, 2024 $1.41M
Capex Q2 2024 · Jun 30, 2023 $6.04M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$77.24M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$97.06M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $141.49M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $206.18M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $70.04M
Stockholders Equity Q2 2024 · Jun 30, 2024 $546.09M
Stockholders Equity Q2 2024 · Mar 31, 2024 $583.07M
Stockholders Equity Q2 2024 · Dec 31, 2023 $599.5M
Stockholders Equity Q2 2024 · Jun 30, 2023 $465.22M
Stockholders Equity Q2 2024 · Mar 31, 2023 $509.48M
Stockholders Equity Q2 2024 · Dec 31, 2022 $550.93M
Current Liabilities Q2 2024 · Jun 30, 2024 $40.37M
Current Liabilities Q2 2024 · Dec 31, 2023 $37.01M
Total Liabilities Q2 2024 · Jun 30, 2024 $154.82M
Total Liabilities Q2 2024 · Dec 31, 2023 $153.19M
Current Assets Q2 2024 · Jun 30, 2024 $590.89M
Current Assets Q2 2024 · Dec 31, 2023 $637.95M
Total Assets Q2 2024 · Jun 30, 2024 $700.91M
Total Assets Q2 2024 · Dec 31, 2023 $752.69M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.59
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.18
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.87
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.71
Eps Basic Q2 2024 · Jun 30, 2024 −$0.59
Eps Basic Q2 2024 · Jun 30, 2024 −$1.18
Eps Basic Q2 2024 · Jun 30, 2023 −$0.87
Eps Basic Q2 2024 · Jun 30, 2023 −$1.71
Sga Expense Q2 2024 · Jun 30, 2024 $14.55M
Sga Expense Q2 2024 · Jun 30, 2024 $28.71M
Sga Expense Q2 2024 · Jun 30, 2023 $13.42M
Sga Expense Q2 2024 · Jun 30, 2023 $25.97M
Rd Expense Q2 2024 · Jun 30, 2024 $50.98M
Rd Expense Q2 2024 · Jun 30, 2024 $99.36M
Rd Expense Q2 2024 · Jun 30, 2023 $47.26M
Rd Expense Q2 2024 · Jun 30, 2023 $94.37M
Net Income Q2 2024 · Jun 30, 2024 −$49.81M
Net Income Q2 2024 · Jun 30, 2024 −$98.54M
Net Income Q2 2024 · Mar 31, 2024 −$48.74M
Net Income Q2 2024 · Jun 30, 2023 −$53.98M
Net Income Q2 2024 · Jun 30, 2023 −$105.96M
Net Income Q2 2024 · Mar 31, 2023 −$51.98M
Operating Income Q2 2024 · Jun 30, 2024 −$58.84M
Operating Income Q2 2024 · Jun 30, 2024 −$115.68M
Operating Income Q2 2024 · Jun 30, 2023 −$58.58M
Operating Income Q2 2024 · Jun 30, 2023 −$116.84M